MENU
LQDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Liquidia (LQDA) Ownership - Who owns Liquidia?

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

Profile

Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.39B
P/E Ratio
N/A
Total Cash
173.42M
Projected Growth
N/A
Total Debt
200.38M
Revenue
19.32M
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash/Share
2.01
Total Debt/Equity
N/A
Revenue/Share
0.23 USD as % of share price

Fundamentals

LQDA
Capitalization
2.39B
P/E Ratio
N/A
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash
173M
Total Cash/Share
2.01
Total Debt
200M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.23%
Revenue
19.3M
ROE
N/A
Book Value
15.2M
P/B Ratio
156.25
Cash Flow
N/A
Earnings
-1.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
85K
Current Ratio
2.49
Current Revenue Per Employee
51982.35
Dividends Per Share - Security
N/A
EBITDA
-133.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.06
Revenue To Assets
-69.73
Shares Held By Institutions
980M
Shares Outstanding - Current
86.1M
Total Liabilities
242M
Total Volume MTD
N/A
Value
-1
Gain YTD
135.799
View a ticker or compare two or three
LQDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LQDA showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of particle-based vaccines and therapeutics for prevention and treatment of human disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
419 Davis Drive
Phone
+1 919 328-4400
Employees
145
Web
https://www.liquidia.com